RAPSID: Can peer supprt, delivered as a group or individual intervention, enable people with diabetes and improve their health? A RAndomised controlled trial of Peer Support In type 2 Diabetes

ISRCTN ISRCTN66963621
DOI https://doi.org/10.1186/ISRCTN66963621
Secondary identifying numbers 6521
Submission date
27/04/2012
Registration date
27/04/2012
Last edited
20/03/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Christopher Bunn
Scientific

Wolfson Diabetes Endocringology Clinic
Addenbrookes Hospital
Hills Road
Cambridge
CB2 0QQ
United Kingdom

Email christopher.bunn@addenbrookes.nhs.uk

Study information

Study designRandomised; Interventional; Design type: Process of Care
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Scientific titleRAPSID: Can peer supprt, delivered as a group or individual intervention, enable people with diabetes and improve their health? A RAndomised controlled trial of Peer Support In type 2 Diabetes
Study acronymRAPSID
Study objectivesRAPSID is a 12 month randomised controlled study among 1200 people with Type 2 diabetes across Cambridgeshire and neighbouring counties, assessing the effect of peer support (that is support by other people with diabetes) on metabolic control (eg glucose, weight, blood pressure). Measures of self management, beliefs and quality of life will be included. The trial includes 4 groups: all receive special educational information, 25% also receive 1:1 peer support, 25% group support and 25% both group and peer support. The peers will be trained and monitored in their work and will be supported by a nurse who will link them with GP/diabetes services if needed.

The RAPSID study is based on a fully evaluated pilot which included (i) Formative evaluation in existing groups to assist with the peer support design (ii) discussions with other global groups about the design and (iii) a full pilot of the three interventions.

The Main Trial commenced with a mail survey of barriers to care to understand who volunteers to come into the trial and to identify potential peers along with an invitation to participate. Randomisation is by geographical area.

More details can be found at http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=6521
Ethics approval(s)10/H0308/72
Health condition(s) or problem(s) studiedTopic: Diabetes Research Network, Primary Care Research Network for England; Subtopic: Type 2, Not Assigned; Disease: Diabetic Control
InterventionPeer support, support by others with diabetes; Follow Up Length: 12 month(s)
Intervention typeOther
Primary outcome measureHbA1c; Timepoint(s): 6 and 12 months
Secondary outcome measures1. Blood pressure (BP) and lipids; Timepoint(s): 6 and 12 months
2. EQ5D quality of life; Timepoint(s): 6 and 12 months
Overall study start date04/01/2011
Completion date30/11/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 1200; UK Sample Size: 1200; Description: 4 cells in a 2x2 factorial design-ie 300 in each including 300 controls
Key inclusion criteriaMale and female particiants with type 2 diabetes aged between 18 and 80 years.; Target Gender: Male & Female
Key exclusion criteria1. >18 years or <80 years
Date of first enrolment04/01/2011
Date of final enrolment30/11/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Wolfson Diabetes Endocringology Clinic
Cambridge
CB2 0QQ
United Kingdom

Sponsor information

Cambridge University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Children's Service
Box No 181, Addenbrookes Hospital
Hills Road
Cambridge
CB2 0QQ
England
United Kingdom

ROR logo "ROR" https://ror.org/04v54gj93

Funders

Funder type

Government

American Academy of Family Physicians Foundation Peers for Progress Program

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 18/03/2015 Yes No